TLPH: Talphera, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14.53
Enterprise Value ($M) 8.72
Book Value ($M) 16.33
Book Value / Share 0.96
Price / Book 0.89
NCAV ($M) 7.51
NCAV / Share 0.44
Price / NCAV 1.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.80
Return on Equity (ROE) -1.36

Liquidity (mrq)
Quick Ratio 5.97
Current Ratio 5.97

Balance Sheet (mrq) ($M)
Current Assets 19.95
Assets 28.77
Liabilities 12.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.65
Operating Income -16.89
Net Income -18.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.49
Cash from Investing -0.53
Cash from Financing 3.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 3.01
02-13 13G/A Lind Global Fund II LP 4.20
01-23 13D Nantahala Capital Management, LLC 11.80 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 3,033 7,125 42.57
2024-07-25 1,168 10,422 11.21
2024-07-24 15,911 31,060 51.23
2024-07-23 15,366 72,146 21.30
2024-07-22 4,751 30,177 15.74

(click for more detail)

Similar Companies
TCRX – TScan Therapeutics, Inc. TENK – TenX Keane Acquisition
TKNO – Alpha Teknova, Inc. TNGX – Tango Therapeutics, Inc.
TRDA – Entrada Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io